Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Other financing activities (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Other financing activities for 2 consecutive years, with -$28904.0 as the latest value for Q4 2023.

  • Quarterly Other financing activities changed N/A to -$28904.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $413544.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $4027.0 for FY2025, 7.27% up from the prior year.
  • Other financing activities hit -$28904.0 in Q4 2023 for Bluejay Diagnostics, down from $413544.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $413544.0 in Q3 2023 to a low of -$28904.0 in Q4 2023.